Letter to the Editor: Rifamycin SV MMX was superior to placebo, but was the comparison appropriate?

被引：0
|
作者：
Zhu, Meng [1 ]
Wang, Zhangcheng [1 ]
Tian, Xiangfeng [1 ]
Zhang, Yongsheng [1 ]
机构：
[1] Zhejiang Chinese Med Univ, Sch Basic Med Sci, 548 Binwen Rd, Hangzhou 310053, Zhejiang, Peoples R China
来源：
HEPATOLOGY COMMUNICATIONS | 2024年 / 8卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [11] Letter to the editor: Appropriate use of common accepted methodologies
    Christophe Matthys
    European Journal of Pediatrics, 2015, 174 : 985 - 986
  • [12] Pharmacokinetics and Safety of Rifamycin SV after Single and Multiple Doses of MMX(R) Modified Release Tablets in Healthy Male and Female Volunteers
    Di Stefano, Andrea Francesco Daniele
    Radicioni, Milko Massimiliano
    Vaccani, Angelo
    Mazzetti, Alessandro
    Longo, Luigi Maria
    Moro, Luigi
    ANTIBIOTICS-BASEL, 2021, 10 (02): : 1 - 11
  • [13] Rifamycin SV-MMX® for treatment of travellers' diarrhea: equally effective as ciprofloxacin and not associated with the acquisition of multi-drug resistant bacteria
    Steffen, Robert
    Jiang, Zhi-Dong
    Garcia, Monica L. Gracias
    Araujo, Prithi
    Stiess, Michael
    Nacak, Tanju
    Greinwald, Roland
    DuPont, Herbert L.
    JOURNAL OF TRAVEL MEDICINE, 2018, 25
  • [14] A randomized open label pilot study evaluating the efficacy of two dosing regimens of rifamycin SV MMX in the treatment of small intestinal bacterial overgrowth
    Bradley A. Connor
    Marina Rogova
    Jefferson Garcia
    Morgan Gardner
    Charandeep Waraich
    Victoria Averill
    BMC Gastroenterology, 25 (1)
  • [15] Letter to the editor: GALAD score: Superior surveillance strategy or not?
    Sachan, Anurag
    Kushwah, Saraswati
    HEPATOLOGY, 2022, 76 (02) : E38 - E39
  • [16] Reply to Letter to the Editor: Is nasal saline just a placebo!
    Demirhan, Hasan
    Aksoy, Fadlullah
    Ozturan, Orhan
    Yildirim, Yavuz Selim
    Veyseller, Bayram
    INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY, 2011, 75 (06) : 884 - 885
  • [17] Letter to Editor-response: placebo response rates
    Gyawali, Bishal
    ECLINICALMEDICINE, 2023, 56
  • [18] Letter to the editor: Selection of appropriate statistical methods for prediction model
    Huang, Zhixin
    Yang, Dong
    Huang, Yan
    Xu, Guang
    Liu, Xintong
    HEPATOLOGY, 2022, 75 (05) : 1348 - 1349
  • [19] Response to the letter to the editor "regarding 'anatomy of the superior glenohumeral ligament'"
    Kolts, Ivo
    Busch, Lueder C.
    Kask, Kristo
    JOURNAL OF SHOULDER AND ELBOW SURGERY, 2011, 20 (03) : E29 - E30
  • [20] RIVET TRIAL: PHASE 2 RCT OF RIFAMYCIN SV MMX, A NOVEL RIFAMPIN ANALOGUE, ON GUT-BRAIN AXIS CHANGES IN CIRRHOSIS AND MINIMAL HEPATIC ENCEPHALOPATHY
    Bajaj, Jasmohan S.
    Fagan, Andrew
    Gavis, Edith A.
    Gallagher, Mary Leslie
    Mousel, Travis
    Puri, Puneet
    Fuchs, Michael
    Davis, Brian C.
    Ahluwalia, Vishwadeep
    Cadrain, Robert
    Sikaroodi, Masoumeh
    Gillevet, Patrick M.
    HEPATOLOGY, 2023, 78 : S1 - S2
12345